Director Corning Luke was granted 19,650 shares, increasing direct ownership by 50% to 58,950 units (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
PSTX
Poseida Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2020
Original source Picked up and delivered by Quantisnow in real time